Shares of Save The World Air Inc (OTCBB: ZERO), a California based company involved in developing applied solutions for the oil and delivery systems for the oil pipeline and diesel engine markets, are soaring in today’s trading.
At last check, ZERO shares were trading 82.09% higher at $1.22, with volume up from daily average of 0.881 million to 3.087 million.
The hike in share prices is mainly due to the company’s recent corporate developments and progresses including its increase in number of patents filed to 35 and implementation of Applied Oil Technology in commercial pipelines. CEO Cecil Bond Kyte quoted that the company is in advanced stage negotiations with three large pipeline and petroleum companies to commercialize its technology.
Shares of Liberty Silver Corp (OTCBB: LBSV), a Canada based Mineral Exploration Company, have risen sharply in today’s trading.
At last check, LBSV shares were trading 5.84% higher at $1.45, with volume down from daily average of 0.82 million to 0.49 million. It has gained about 158.93% year to date. The stock has been trading in the range of $1.38 and $1.54 so far in today’s trading.
The stock opened today at $1.38, a price slightly above its previous day close price and increased steeply to its 52 week high of $1.54 within few minutes of market open. Then, it has stabilized around $1.49 and dropped a little to $1.45 by mid half of the session.
Shares of Amarantus Biosciences Inc (OTCBB: AMBS), a California based biotechnology company that develops new treatments for Parkinson’s disease and Traumatic Brain Injury, are soaring in today’s trading.
At last check, AMBS shares were trading 30% higher at $0.0130, with volume down from daily average of 1.54 million to 1.34 million. The stock has been trading so far in the range of $0.0101 and $0.0150. It reached a 52 week high of $0.5 in last November 2011 and deteriorated drastically since then.
AMBS development of treatments is centered on a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF”). It had recently showed positive results in an animal model of myocardial infarction.